In focus
Latest feed
Wockhardt Secures US FDA Approval for Zaynich, Shifts Gears from Lab Bench to Marketplace
A Legal Rollercoaster: Corcept's Stock Takes a Dive as Appeals Court Backs Teva in Key Patent Spat
Biocon Biologics Secures Landmark USFDA Approval for Critical Antibacterial Drug
Lupin Unleashes Affordable Overactive Bladder Treatment in the U.S. Market